Graf Akcie CLB (Core Laboratories N.V.). Diskuze k akciím CLB. Aktuální informace CLB.

Základní informace o společnosti Core Laboratories N.V. (Akcie CLB)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.43B
Hodnota podniku (EV) 1.43B
Tržby 446.259M
EBITDA 75.822M
Zisk 32.665M
Růst v tržbách Q/Q 2.60 %
Růst v tržbách Y/Y -25.39 %
P/E (Cena vůči ziskům) 43.81
Forward P/E 1.29
EV/Sales 3.20
EV/EBITDA 18.86
EV/EBIT 24.46
PEG 0.60
Price/Sales 3.21
P/FCF 87.37
Price/Book 20.03
Účetní hodnota na akcii 1.57
Hotovost na akcii 0.30
FCF vůči ceně 1.14 %
Počet zaměstnanců 3,700
Tržba na zaměstnance 120.611k
Profit margin -20.04 %
Operating margin 13.26 %
Gross margin 23.09 %
EBIT margin 13.10 %
EBITDA margin 16.99 %
EPS - Zisk na akcii 0.72
EPS - Kvartální růst 28.57 %
EPS - Očekávaný růst příští rok 25.00 %
Return on assets 5.58 %
Return on equity 30.31 %
ROIC -11.59 %
ROCE 11.52 %
Dluhy/Equity 6.89
Čistý dluh/EBITDA 14.83
Current ratio 2.21
Quick Ratio 1.79
Volatilita 4.28
Beta 1.53
RSI 62.67
Cílová cena analytiků 19
Známka akcie (dle analytiků) 2.44
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 46.331M
Procento shortovaných akcií 10.82 %
Short ratio 7.80 %
Dividenda 0.04
Procentuální dividenda 0.13 %
Dividenda/Zisk 5.56 %
Obchodovaná od 1995
Země Netherlands

Finanční výsledky akcie CLB

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$487.267$668.21$700.846$647.819$590.232$797.52
Cost Of Goods Sold$374.767$495.579$496.964$464.958$437.503$532.652
Gross Profit$112.5$172.631$203.882$182.861$152.729$264.868
Research And Development Expenses------
SG&A Expenses$34.033$48.023$62.91$47.737$39.39$72.672
Other Operating Income Or Expenses$-134.405$-5.319$0.737$-0.632$0.4$-3.669
Operating Expenses$564.072$571.526$582.224$537.851$502.781$636.45
Operating Income$-76.805$96.684$118.622$109.968$87.451$161.07
Total Non-Operating Income/Expense$-14.372$-14.69$-13.328$-10.734$-11.572$-12.38
Pre-Tax Income$-91.177$81.994$105.294$99.234$75.879$148.69
Income Taxes$5.896$-12.29$25.447$18.249$10.855$33.758
Income After Taxes$-97.073$94.284$79.847$80.985$65.024$114.932
Other Income------
Income From Continuous Operations$-97.073$94.284$79.847$80.985$65.024$114.932
Income From Discontinued Operations$-0.424$7.833$-0.058$2.111$-1.165-
Net Income$-97.637$101.983$79.526$83.125$63.895$114.847
EBITDA$-55.938$119.289$141.709$134.492$114.323$188.527
EBIT$-76.805$96.684$118.622$109.968$87.451$161.07
Basic Shares Outstanding444444444343
Shares Outstanding444544444443
Basic EPS$-2.20$2.30$1.80$1.88$1.47$2.69
EPS - Earnings Per Share$-2.20$2.28$1.79$1.88$1.46$2.68
# 2020 2019 2018 2017 2016 2015
Current Ratio1.84791.98252.25242.06241.79251.9754
Long-term Debt / Capital0.77440.62630.6430.60410.58231.0582
Debt/Equity Ratio3.43291.67611.80091.52621.394-18.1859
Gross Margin23.08825.834829.090828.227225.876133.2115
Operating Margin-15.762414.469116.925616.975114.816420.1964
EBIT Margin-15.762414.469116.925616.975114.816420.1964
EBITDA Margin-11.4817.85220.219720.760719.369223.6392
Pre-Tax Profit Margin-18.711912.270715.023815.318212.855818.6441
Net Profit Margin-20.037715.262111.347112.831510.825414.4005
Asset Turnover0.8570.86261.08021.10771.031.2755
Inventory Turnover Ratio9.82339.879410.883113.955612.974613.0214
Receiveable Turnover5.24694.83844.89594.60744.88785.216
Days Sales In Receivables69.564575.438474.552479.220974.67569.9766
ROE - Return On Equity-128.449351.764649.625254.450341.8707-484.9656
Return On Tangible Equity299.1-193.4624-111.5712-203.9514-193.0469-54.2391
ROA - Return On Assets-17.072912.170812.306413.84811.34718.3815
ROI - Return On Investment-28.976519.343417.717421.554617.489728.2189
Book Value Per Share1.69554.09623.63073.36623.5174-0.5593
Operating Cash Flow Per Share-0.7042-0.5091-0.2931-0.2126-2.0862-1.6975
Free Cash Flow Per Share-0.4533-0.5191-0.3538-0.3778-1.8287-1.3976